# LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

> **NCT01198054** · PHASE4 · TERMINATED · sponsor: **PETHEMA Foundation** · enrollment: 4 (actual)

## Conditions studied

- AML

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01198054
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198054, "LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01198054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*